Treace Announces First Patient Treated in Mini3D™ Lapiplasty® Clinical Study

NEXT STORY
Fate Therapeutics Announces Presentations at the Society for Immunotherapy of Cancer 2021 Annual Meeting
PREV STORY
G1 Therapeutics Announces Permanent J-Code from Centers for Medicare and Medicaid Services
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Junshi Biosciences and Coherus Announce FDA Acceptance of BLA Filing for Toripalimab for Treatment of Nasopharyngeal Carcinoma

author_avatar
NASDAQ Market News

RedHill Biopharma Receives U.S. Patent Allowance Covering Opaganib and RHB-107 Combination

author_avatar
NASDAQ Market News

Capacity and Capabilities of South Africa’s Healthcare System in 2020

author_avatar
NASDAQ Market News